RecruitingNCT07579481
Vortioxetine use in people with depression and migraine
About this title
Read the official source — NCT07579481Observational studyAges 18+Italy
Understand this study
Who could participate?
This study is for people with depression. Listed age limits: from 18 years. Other eligibility criteria apply.
- Listed locations
- RomeSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: April 28, 2025
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 31
- Sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Sponsor type
- Unknown or unclear
- Study type
- Observational
- Intervention type
- Interview / survey / observational
- Locations
- Italy
- Age range
- Over 18 Years
- Official registry ID
- NCT07579481
- Official title
Show the full official title
Vortioxetine in the Treatment of Depression and Concomitant Migraine: an Explorative Study
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Rome
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Fondazione Policlinico Universitario Agostino Gemelli IRCCS.
Who can participate?
This study is for people with depression. Listed age limits: from 18 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as recruiting.
